Lotus Ventures Inc (CSE:J)(Frankfurt: LV9), announces its initial product information, expected to be sold in the second half of 2019. The Company has imported 3,500 seeds, 229 strains and 75 live plants into the facility. These form the basis of the Lotus catalogue. We also anticipate growing proprietary strains which can be licensed to other licensed producers or used in various partnerships.

Even though legalization for recreational use took effect in October 2018, the sector remains constrained by the availability of high-quality cannabis. The Lotus product line is targeted to the higher end recreational segment of the market. Like the wine or spirits business, the high-end of the market commands much higher financial margins.


The following strains will become recognizable by the discerning cannabis consumer and are expected to be grown during the initial ramp-up stage: Goji OG, Kalifornia, Space Cake, MAC, Ancient’s Breath, Soul Food, Purple Urkle, Northern Lights #5 and proprietary variations of Hashplant.

“We have a very large and diverse list of cultivars to select from and our team has experience with each live plant we’ve imported, so we feel very confident with our starting lineup.” said COO, Carl Correia.

Appointment: Lotus announces Maurice Creagh replacing Gary Mathiesen as CFO. Gary Mathiesen stepped down after Lotus received its Standard Cultivation license, and the Company wishes him all the best moving forward. Maurice Creagh, a long-term construction executive and an early investor in Lotus, was a co-founder of Ventana Construction which has grown to annual construction volumes in the range of $300 to $600 million. Now semi-retired, Maurice Creagh continues to be active as an advisor on development and construction to municipalities, developers and investors. Maurice has been a director of several companies and a director of the Independent Contractors and Business Association of BC (ICBA) from 1998 to 2006.

ON BEHALF OF THE BOARD
Lotus Ventures Inc.
“Dale McClanaghan”
Dale McClanaghan, President and CEO

About Lotus Ventures Inc.
Lotus Ventures Inc. (CSE:J) is an Okanagan-based licensed cannabis producer focused on constructing purpose-built facilities with proprietary processes. The Company’s initial operation is a 22,500 square foot facility designed with state-of-the-art air filtering systems, precise environmental control and a horticulture program adhering to Good Production Practices (GPP). Lotus designed its facility concentrating on low production costs and high margin products.

Lotus currently holds a Standard Cultivation license and Sale for Medical Purposes license pursuant to the Cannabis Actand Cannabis Regulations. The licenses were obtained by Lotus on March 8, 2019, less than a month after submitting its Evidence Package to Health Canada, being one of the fastest in the industry to do so.

The Company recently launched its initial consumer-brand, ‘Lotus Cannabis Co.’ targeting the discerning cannabis connoisseur. With a seed library of over 200 strains to choose from, Lotus is set to grow only the best cannabis. The Company has an offtake agreement with Auxly Cannabis Group Inc. which gives Lotus the right to sell up to 50% of the initial facility’s production.

Lotus’ plant genetics along with its facility design, standard operating procedures, growing methods, and application support can be licensed to farmers and other licensed producers across Canada who see the value in cultivating premium products at low production costs.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

For further information: Dale McClanaghan, CEO: dalemcclanaghan@gmail.com (604) 644-9844; Daniel McRobert, Investor Relations: investors@lotuscannabis.ca (604) 842-4625

Click here to connect with Lotus Ventures Inc (CSE:J) for an Investor Presentation. 

Source: www.newswire.ca

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE:ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws

Keep reading... Show less

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced Jason Ackerman Chief Executive Officer and Executive Chairman of TerrAscend, Keith Stauffer Chief Financial Officer, and Jason Wild Chairman, will participate in three upcoming conferences:

  • Cowen’s 3rd Annual Boston Cannabis Conference, a virtual event taking place November 30-December 2 , 2020. Jason Ackerman will participate in a panel, U.S. MSOs: The West, on November 30, 2020 at 10:25 a.m. ET . Management will also host one-on-one meetings with investors throughout the conference.
  • 2020 Cantor Fitzgerald Virtual Cannabis MSO Summit, a virtual event taking place on December 15-16, 2020 . Jason Ackerman is scheduled to participate in a fireside chat on December 16 th at 1:00 p.m. ET . To register for the fireside chat: Click Here
  • 23 rd Annual Needham Virtual Growth Conference, a virtual event taking place January 11-15, 2021 . Jason Ackerman is scheduled to participate in a fireside chat on January 14, 2021 at 2:45 p.m. ET . Management will also host one-on-one meetings with investors throughout the conference. To register for the fireside chat: Click Here

The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Keep reading... Show less
  • Aurora strategically positioned within two of the largest legal cannabis markets outside of Canada
  • Agreement with Israeli leader Cantek provides access to Israel’s drugstore channel
  • Finished product is co-branded under Aurora and Cantek brands

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today it has entered into a strategic Supply Agreement (the “Agreement”) with Cantek Holdings (“Cantek”), one of Israel’s leaders in the medical cannabis field.

Keep reading... Show less